CBD for epilepsy

This report demonstrates an anticonvulsant effect in mice with epilepsy. Confirming the need for a review of previous trials in this treatment. ‘We have recently shown that the phytocannabinoid cannabidiol (CBD) reduces seizure severity and lethality in the well-established in vivo model of pentylenetetrazole-induced generalised seizures, suggesting that earlier, small-scale clinical trials examining CBD effects in people with epilepsy warrant renewed attention.’

Conclusion shows ‘These results extend the anticonvulsant profile of CBD; when combined with a reported absence of psychoactive effects, this evidence strongly supports CBD as a therapeutic candidate for a diverse range of human epilepsies.’

Read the full article HERE…